Experimental drug aims to shrink bulging eyes in autoimmune condition
NCT ID NCT06557850
Summary
This study is testing an investigational drug called Lu AG22515 to see if it can reduce eye bulging in people with moderate-to-severe Thyroid Eye Disease. It follows 20 adults for 24 weeks to measure changes in eye protrusion and track how the drug moves through the body. The goal is to control the autoimmune inflammation that causes this disfiguring and sometimes painful condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Diagnostic-Consultative Center Alexandrovska
Sofia, 1431, Bulgaria
-
Jagiellonian University Medical College
Krakow, Lesser Poland Voivodeship, 30-688, Poland
-
Uniewrsyteckie Centru Kliniczne
Katowice, 40-514, Poland
-
UnivCentrum Zdrowia MDM EB GROUP Sp.zo.o
Warsaw, 00-189, Poland
-
University Clinical Center of The Republic Of Srpska
Banja Luka, Republika Srpska, 78000, Bosnia and Herzegovina
-
University Specialized Hospital for Active Treatment in Endocrinology (USHATE) "Acad. Ivan Penchev"
Sofia, 1431, Bulgaria
Conditions
Explore the condition pages connected to this study.